Verastem Oncology to Present at Upcoming Investor Conferences
March 12 2019 - 6:00AM
Business Wire
Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company),
focused on developing and commercializing medicines seeking to
improve the survival and quality of life of cancer patients, today
announced that the Company will present at the following upcoming
investor conferences:
- The 31st Annual ROTH Conference on
Tuesday, March 19, 2019 at 12:00pm PDT in Dana Point, CA, USA
- The Oppenheimer 29th Annual Healthcare
Conference on Tuesday, March 19, 2019 at 11:30am EDT in New York
City, NY, USA
A live webcast of these presentations will be available on the
investors section of the Company’s website at www.verastem.com. An
archived presentation will be available for 90 days.
About Verastem Oncology
Verastem Oncology (Nasdaq:VSTM) is a commercial
biopharmaceutical company committed to the development and
commercialization of medicines to improve the lives of patients
diagnosed with cancer. We are driven by the strength, tenacity and
courage of those battling cancer – single-minded in our resolve to
deliver new therapies that not only keep cancer at bay, but improve
the lives of patients diagnosed with cancer. Because for us, it’s
personal.
Our first FDA approved product is now available for the
treatment of patients with certain types of indolent non-Hodgkin’s
lymphoma (iNHL). Our pipeline comprises product candidates that
seek to treat cancer by modulating the local tumor
microenvironment. For more information, please visit
www.verastem.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190312005120/en/
Verastem Oncology:Erin CoxSenior Director, Investor Relations
and Corporate Communications+1 781-469-1553ecox@verastem.com
Investors:Joseph RayneArgot Partners+1
617-340-6075joseph@argotpartners.com
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Apr 2024 to May 2024
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From May 2023 to May 2024